Huub Schellekens, Wim Jiskoot. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Adverse Drug Reaction Reporting SystemsEpoetin AlfaErythropoietin/adverse effectsErythropoietin/therapeutic useHematinics/adverse effectsHematinics/therapeutic useHumansKidney Failure, Chronic/drug therapyKidney Failure, Chronic/epidemiologyRecombinant ProteinsRed-Cell Aplasia, Pure/chemically inducedRed-Cell Aplasia, Pure/epidemiologyRisk Assessment/methodsRisk Factors
Substances: See more » HematinicsRecombinant ProteinsErythropoietinEpoetin Alfa
Year: 2006 PMID: 16763579 DOI: 10.1038/nbt0606-613
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908